A detailed history of Rothschild Investment LLC transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 110 shares of TERN stock, worth $805. This represents 0.0% of its overall portfolio holdings.

Number of Shares
110
Previous 40 175.0%
Holding current value
$805
Previous $272,000 237.13%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$6.49 - $10.8 $454 - $756
70 Added 175.0%
110 $917,000
Q2 2024

Jul 30, 2024

BUY
$4.54 - $8.2 $181 - $328
40 New
40 $272,000

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $275M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.